KINEX LABS products are sold exclusively for in-vitro research and laboratory use. By entering, you confirm you are 18 or older and a qualified researcher, and you will not use these compounds for human consumption.
Retatrutide 40 mg is the highest-concentration format we offer of the triple-agonist peptide Retatrutide. Intended for laboratory research requiring extended working stock from a single vial.
Research Profile
Triple-agonist activity across GIP, GLP-1, and glucagon receptors
Studied in metabolic, energy-expenditure, and glucose-handling research
Maximum-concentration format for long-term studies
QC verified by HPLC and mass spectrometry
Specifications
Compound: Retatrutide (LY3437943)
Dosage: 40 mg per vial
Purity: ≥ 98% (HPLC)
Form: Lyophilized powder
Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
